{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:22:14Z","timestamp":1787764934777,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Specific microRNA (miRNA) expression signatures have been identified in a variety of human cancers. More recently, increasing evidence shows that miRNAs exist in human blood serum and plasma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Levels of miR-185 in plasma were measured by quantitative reverse-transcriptase polymerase chain reaction in 66 glioma patients, 11 pituitary adenoma patients, 32 meningioma patients, and 14 acoustic neuroma patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The plasma levels of miR-185 were significantly altered in glioma patients compared to normal controls. However, its levels were not observably changed in patients with other brain tumors such as meningioma, acoustic neuroma, or pituitary adenoma. Furthermore, the plasma levels of miR-185 in glioblastoma multiforme patients with operation and chemo-radiation almost revived to normal levels. Finally, we also demonstrated that low plasma miR-185 levels are correlated with poor survival in glioma patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>These findings suggest that plasma miR-185 has become potential biomarkers for glioma and may be useful in clinical management for glioma patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0973-1482.146121","type":"journal-article","created":{"date-parts":[[2015,10,9]],"date-time":"2015-10-09T11:54:49Z","timestamp":1444391689000},"page":"630-634","source":"Crossref","is-referenced-by-count":47,"title":["Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma"],"prefix":"10.4103","volume":"11","author":[{"given":"Hailin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20231126","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.semradonc.2009.02.001","article-title":"Beyond grade: Molecular pathology of malignant gliomas","volume":"19","author":"Sulman","year":"2009","journal-title":"Semin Radiat Oncol"},{"key":"R2-20-20231126","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ijc.27657","article-title":"Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas","volume":"132","author":"Yang","year":"2013","journal-title":"Int J Cancer"},{"key":"R3-20-20231126","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1158\/1078-0432.CCR-09-0695","article-title":"Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival","volume":"15","author":"Ernst","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R4-20-20231126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1756-9966-31-97","article-title":"Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma","volume":"31","author":"Wang","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"key":"R5-20-20231126","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10571-011-9697-y","article-title":"Brain tumor microvesicles: Insights into intercellular communication in the nervous system","volume":"31","author":"van der Vos","year":"2011","journal-title":"Cell Mol Neurobiol"},{"key":"R6-20-20231126","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ncb1800","article-title":"Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers","volume":"10","author":"Skog","year":"2008","journal-title":"Nat Cell Biol"},{"key":"R7-20-20231126","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1471-4159.2011.07307.x","article-title":"A specific miRNA signature in the peripheral blood of glioblastoma patients","volume":"118","author":"Roth","year":"2011","journal-title":"J Neurochem"},{"key":"R8-20-20231126","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1476-4598-10-124","article-title":"MiR-185 targets the DNA methyltransferases 1 and regulates global DNA methylation in human glioma","volume":"10","author":"Zhang","year":"2011","journal-title":"Mol Cancer"},{"key":"R9-20-20231126","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2174\/156800912803251180","article-title":"LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway","volume":"12","author":"Tang","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"R10-20-20231126","doi-asserted-by":"crossref","first-page":"46367","DOI":"10.1371\/journal.pone.0046367","article-title":"Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma","volume":"7","author":"Zeng","year":"2012","journal-title":"PLoS One"},{"key":"R11-20-20231126","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nrclinonc.2013.80","article-title":"Circulating tumour cells and cell-free DNA as tools for managing breast cancer","volume":"10","author":"De Mattos-Arruda","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"R12-20-20231126","first-page":"311","article-title":"miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer","volume":"39","author":"Ak\u00e7akaya","year":"2011","journal-title":"Int J Oncol"},{"key":"R13-20-20231126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.canlet.2010.11.009","article-title":"miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells","volume":"301","author":"Liu","year":"2011","journal-title":"Cancer Lett"},{"key":"R14-20-20231126","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.biopha.2013.03.022","article-title":"Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage","volume":"67","author":"Zhi","year":"2013","journal-title":"Biomed Pharmacother"},{"key":"R15-20-20231126","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/onc.2012.575","article-title":"MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: A novel epigenetic therapy independent of decitabine","volume":"33","author":"Xiang","year":"2014","journal-title":"Oncogene"},{"key":"R16-20-20231126","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1038\/onc.2010.233","article-title":"MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers","volume":"29","author":"Imam","year":"2010","journal-title":"Oncogene"},{"key":"R17-20-20231126","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11010-013-1576-z","article-title":"MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor","volume":"377","author":"Qu","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"R18-20-20231126","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1158\/1078-0432.CCR-12-3675","article-title":"GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle","volume":"19","author":"Yoon","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R19-20-20231126","doi-asserted-by":"crossref","first-page":"e13735","DOI":"10.1371\/journal.pone.0013735","article-title":"A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer","volume":"5","author":"Zhao","year":"2010","journal-title":"PLoS One"},{"key":"R20-20-20231126","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1479-5876-10-42","article-title":"De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer","volume":"10","author":"Wu","year":"2012","journal-title":"J Transl Med"},{"key":"R21-20-20231126","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2217\/fon.12.192","article-title":"Circulating miRNAs as new blood-based biomarkers for solid cancers","volume":"9","author":"Redova","year":"2013","journal-title":"Future Oncol"},{"key":"R22-20-20231126","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/cncr.26565","article-title":"Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients","volume":"118","author":"Jung","year":"2012","journal-title":"Cancer"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201511030-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:51:41Z","timestamp":1787763101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201511030-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4103\/0973-1482.146121","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}